Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...

Samples will be processed at the company’s lab in California, US. Quest Diagnostics neurology general manager and ...

Leriglitazone appeared to stop disease progress both clinically and via imaging in a small cohort of boys with cerebral ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

"Nihon Kohden expands neurology portfolio with Ad-Tech Medical acquisition" was ... The information on this site has been included in good faith for general informational purposes only.

Fremanezumab is a calcitonin-gene related peptide (CGRP) pathway monoclonal antibody that is FDA approved for adults with ...

Why? Because many of the most common diseases share the same risk factors,” Dr. Jonathan Rosand, chair of neurology at MGH, said in a news release. People can protect their brain health by improving ...

Researchers have dosed the first participant in a clinical trial of an investigational medicine designed to lower the amount ...

NEW YORK, April 11, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up ...

By Dr. Liji Thomas, MD A new study links two widely prescribed diabetes drugs to a 33–43% lower risk of Alzheimer’s and ...

Earlier research shows marijuana users are nearly 25% more likely to need emergency care and hospitalization than nonusers.